Phase 2 Graft Dysfunction Clinical Trials

3 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–3 of 3 trials

Recruiting

Phase 2

LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome.

Bronchiolitis Obliterans SyndromeLung transplantationChronic lung allograft dysfunction

Steven Hays, MD30 enrolled1 locationNCT06018766

Recruiting

Phase 2

This Study is Assessing the Safety and Efficacy of Immune Inhibition as a Treatment to Prevent Primary Graft Dysfunction

Acute Lung Injury(ALI)Natural Killer Cell Mediated ImmunityPrimary Graft Dysfunction+1 more

University of California, San Francisco120 enrolled1 locationNCT06853223

Recruiting

Phase 1Phase 2

Chronic Lung Allograft Dysfunction MRI Study

Chronic Lung Allograft Dysfunction Lung MRI (CLAD)

Sean Fain100 enrolled1 locationNCT06406777